Clinical Trials Browser

Phase 3 × Nevus, Blue × pembrolizumab × Clear all

NCT05549297 2026-02-25

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Phase 3 Recruiting

Melanoma, Nevus, Blue